全文获取类型
收费全文 | 8920篇 |
免费 | 681篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 250篇 |
妇产科学 | 199篇 |
基础医学 | 1625篇 |
口腔科学 | 71篇 |
临床医学 | 865篇 |
内科学 | 1998篇 |
皮肤病学 | 201篇 |
神经病学 | 1036篇 |
特种医学 | 241篇 |
外科学 | 875篇 |
综合类 | 16篇 |
一般理论 | 2篇 |
预防医学 | 768篇 |
眼科学 | 109篇 |
药学 | 601篇 |
中国医学 | 7篇 |
肿瘤学 | 749篇 |
出版年
2024年 | 7篇 |
2023年 | 94篇 |
2022年 | 137篇 |
2021年 | 304篇 |
2020年 | 169篇 |
2019年 | 217篇 |
2018年 | 312篇 |
2017年 | 182篇 |
2016年 | 240篇 |
2015年 | 284篇 |
2014年 | 398篇 |
2013年 | 498篇 |
2012年 | 762篇 |
2011年 | 753篇 |
2010年 | 385篇 |
2009年 | 409篇 |
2008年 | 609篇 |
2007年 | 638篇 |
2006年 | 601篇 |
2005年 | 655篇 |
2004年 | 519篇 |
2003年 | 521篇 |
2002年 | 416篇 |
2001年 | 43篇 |
2000年 | 35篇 |
1999年 | 62篇 |
1998年 | 89篇 |
1997年 | 64篇 |
1996年 | 41篇 |
1995年 | 39篇 |
1994年 | 29篇 |
1993年 | 24篇 |
1992年 | 13篇 |
1991年 | 12篇 |
1990年 | 7篇 |
1988年 | 6篇 |
1986年 | 5篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1982年 | 2篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1974年 | 2篇 |
1973年 | 5篇 |
1972年 | 2篇 |
1964年 | 2篇 |
1962年 | 3篇 |
1961年 | 2篇 |
1893年 | 1篇 |
排序方式: 共有9637条查询结果,搜索用时 0 毫秒
71.
Micha?l Philippe Emilie Hénin Yves Bertrand Dominique Plantaz Sylvain Goutelle Nathalie Bleyzac 《The AAPS journal》2015,17(5):1157-1167
Optimal immunosuppressive therapy in acquired severe aplastic anemia (SAA) remains to be refined, especially cyclosporine (CsA) use. Current recommendations state that CsA trough blood concentrations (TBC) should be maintained between 200 and 400 ng/mL despite the lack of supporting data. This study aimed at quantifying relationships between CsA exposure and neutrophil response and determining an effective range for CsA TBC. Twenty-three SAA patients treated with CsA were retrospectively analyzed. Nonlinear mixed effect modeling approaches were used to develop a pharmacokinetic-pharmacodynamic model. The pharmacokinetic model described the relationships between CsA doses and TBC. The pharmacodynamic model allowed to estimate boundaries for optimal CsA effects, neutrophils being used as biomarker of response. A time-to-event model linked effective concentration to time-to-therapeutic success. CsA TBC were adequately described by a two-compartment model with first-order absorption, a lag time, and a linear elimination. The efficient range of CsA TBC was estimated between 87 and 120 ng/mL. Model-based simulations and external validation in three additional patients confirmed these results. This original modeling approach was successful in describing the relationship between CsA TBC and neutrophil response in SAA patients. Although further evaluation of the model is necessary, this work suggests that an optimal CsA TBC target of 100 ng/mL would be associated with a better neutrophil response in children with SAA.KEY WORDS: aplastic anemia, cyclosporine, modeling, pharmacokinetics, regulatory T lymphocytes 相似文献
72.
Effectiveness of intervention led by a community pharmacist for improving recognition of sleep apnea in primary care – a cohort study 下载免费PDF全文
Clémence Perraudin Bernard Fleury Nathalie Pelletier‐Fleury 《Journal of sleep research》2015,24(2):167-173
Despite its high prevalence and major public health ramifications, obstructive sleep apnea syndrome (OSAS) remains underdiagnosed. The aim of this study was to determine whether the involvement of a community pharmacist (CP) in the care pathway of a patient at risk of OSAS, through the implementation of a community pharmacist (CP) intervention, was effective, i.e. increased the use of diagnostic tests in this population. We compared a cohort of patients included in a research protocol (exposed to a CP intervention) with patients having the same characteristics taken from a general population database who did not receive the intervention (unexposed group). The aim of the CP intervention was to educate patients about the risk of untreated OSAS, encouraging them to consult their general practitioner, and urging the doctor to continue investigations. We included 782 patients at risk of OSAS, i.e. taking one or more anti‐hypertensive drugs, being overweight (body mass index >25) and snoring almost every night (88 in the exposed group and 694 in the unexposed group). After a 6‐month follow‐up, the number of patients who underwent an OSAS diagnostic test was significantly higher in the exposed group compared to the unexposed group (22.7 versus 11.4%, P = 0.003). Being exposed to the pharmacist intervention was associated with a higher chance of undergoing a diagnostic test for OSAS, adjusted odds ratio: 2.24 (1.25–4.01). In conclusion, these findings provide arguments for the implementation of a CP OSAS screening intervention in CP routine practice. 相似文献
73.
Andreas Bielmann Nicolas Sambiagio Nathalie Wehr Sandrine Gerber-Lemaire Christian G. Bochet Christophe Curty 《RSC advances》2018,8(42):23881
Sulfur Mustard (SM) is a blistering agent used as a chemical weapon. Glutathione (GSH) is involved in the β-lyase degradation pathway of SM and recently, bioadducts between SM and GSH were observed in vitro. While these bioadducts have never been isolated from in vivo tests or real poisoning with SM, they could be of interest as potential future biomarkers for the retrospective validation of exposure. We herein report the synthesis of different observed and new potential GSH–SM bioadducts as reference materials for analytical investigation. Two distinct approaches were investigated: a building-block pathway and the direct reaction with GSH. The availability of these references will aid future studies and may lead to the discovery of new GSH–SM biomarkers.Recently, several adducts between the chemical agent sulfur mustard (SM) and glutathione (GSH) were observed in vitro. We report the synthesis of different observed and potential GSH–SM bioadducts as reference materials for analytical investigation. 相似文献
74.
Elske M. Brouwer-Brolsma Rosalie A. M. Dhonukshe-Rutten Janneke P. van Wijngaarden Nikita L. van der Zwaluw Nathalie van der Velde Lisette C. P. G. M. de Groot 《Nutrients》2015,7(9):7781-7797
Low vitamin B-12 concentrations are frequently observed among older adults. Malabsorption is hypothesized to be an important cause of vitamin B-12 inadequacy, but serum vitamin B-12 may also be differently affected by vitamin B-12 intake depending on food source. We examined associations between dietary sources of vitamin B-12 (meat, fish and shellfish, eggs, dairy) and serum vitamin B-12, using cross-sectional data of 600 Dutch community-dwelling adults (≥65 years). Dietary intake was assessed with a validated food frequency questionnaire. Vitamin B-12 concentrations were measured in serum. Associations were studied over tertiles of vitamin B-12 intake using P for trend, by calculating prevalence ratios (PRs), and splines. Whereas men had significantly higher vitamin B-12 intakes than women (median (25th–75th percentile): 4.18 (3.29–5.38) versus 3.47 (2.64–4.40) μg/day), serum vitamin B-12 did not differ between the two sexes (mean ± standard deviation (SD): 275 ± 104 pmol/L versus 290 ± 113 pmol/L). Higher intakes of dairy, meat, and fish and shellfish were significantly associated with higher serum vitamin B-12 concentrations, where meat and dairy—predominantly milk were the most potent sources. Egg intake did not significantly contribute to higher serum vitamin B-12 concentrations. Thus, dairy and meat were the most important contributors to serum vitamin B-12, followed by fish and shellfish. 相似文献
75.
76.
77.
Non‐clinical safety evaluation of single and repeated intramuscular administrations of MAGE‐A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys 下载免费PDF全文
Eric Destexhe Emilie Grosdidier Nathalie Baudson Roy Forster Catherine Gerard Nathalie Garçon Lawrence Segal 《Journal of applied toxicology : JAT》2015,35(7):717-728
The MAGE‐A3 recombinant protein combined with AS15 immunostimulant (MAGE‐A3 Cancer Immunotherapeutic) is under development by GlaxoSmithKline for the treatment of lung cancer and melanoma. We performed non‐clinical safety studies evaluating potential local and systemic toxic effects induced by MAGE‐A3 Cancer Immunotherapeutic in rabbits (study 1) and cynomolgus monkeys (study 2). Animals were allocated to two groups to receive a single (rabbits) or 25 repeated (every 2 weeks) injections (monkeys) of MAGE‐A3 Cancer Immunotherapeutic (treatment groups) or saline (control groups). All rabbits were sacrificed 3 days post‐injection and monkeys 3 days following last injection (3/5 per gender per group) or after a 3‐month treatment‐free period (2/5 per gender per group). Local and systemic reactions and MAGE‐A3‐specific immune responses (monkeys) were assessed. Macroscopic and microscopic (for rabbits, injection site only) post‐mortem examinations were performed on all animals. No systemic toxicity or unscheduled mortalities were recorded. Single (rabbits) and repeated (monkeys; up to four times at the same site) injections were well tolerated. Following five to seven repeated injections, limb circumferences increased up to 26% (5 h post‐injection), but returned to normal after 1–8 days. Three days after the last injection, enlargements of iliac, popliteal, axillary and inguinal lymph nodes, and increased incidence or severity of mononuclear inflammatory cell infiltrates was observed in injected muscles of treated monkeys. No treatment‐related macroscopic findings were recorded after the treatment‐free period. MAGE‐A3‐specific antibody and T‐cell responses were raised in all treated monkeys, confirming test item exposure. Single or repeated intramuscular injections of MAGE‐A3 Cancer Immunotherapeutic were well tolerated in rabbits and monkeys. Copyright © 2014 GlaxoSmithKline Vaccines. Journal of Applied Toxicology published by John Wiley & Sons, Ltd. 相似文献
78.
79.
80.
Bonnefoy Pierre-Benoît Prevot Nathalie Mehdipoor Ghazaleh Sanchez Alicia Lima Jorge Font Llorenç Gil-Díaz Aída Llamas Pilar Aibar Jesús Bikdeli Behnood Bertoletti Laurent Monreal Manuel 《Journal of thrombosis and thrombolysis》2022,53(4):829-840
Journal of Thrombosis and Thrombolysis - Ventilation/perfusion (V/Q) imaging and computed tomography pulmonary angiography (CTPA) are common tools for acute pulmonary embolism (PE) diagnosis.... 相似文献